Literature DB >> 15823279

Smoking is associated with advanced coronary atherosclerosis in youth.

Arthur W Zieske1, C Alex McMahan, Henry C McGill, Satoki Homma, Hidehiro Takei, Gray T Malcom, Richard E Tracy, Jack P Strong.   

Abstract

Smoking is linked to atherosclerosis and coronary heart disease (CHD) in older adults. However, evidence that smoking affects coronary atherosclerosis in young people is incomplete. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study collected arteries, blood, and other tissues from persons 15 to 34 years of age dying of external causes and autopsied in forensic laboratories. Lesions in the proximal left anterior descending coronary arteries (LAD) from 1127 subjects were graded microscopically according to the American Heart Association criteria. Among individuals with advanced lesions (Grade 4 or 5), smokers had a greater prevalence of Grade 5 lesions than non-smokers (odds ratio 9.61, 95% confidence interval 2.34-39.57), a difference suggesting that smoking accelerates the transition from Grade 4 to Grade 5 lesions. This association occurred among both men and women, and among persons with and without other CHD risk factors. The difference in qualities of advanced lesions suggests that smoking possibly accelerates the transition from Grade 4 to Grade 5 lesions by promoting thrombosis and accretion on the intimal surface of the plaque.

Entities:  

Mesh:

Year:  2004        PMID: 15823279     DOI: 10.1016/j.atherosclerosis.2004.10.039

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Effect of smoking on age at the time of coronary artery bypass graft surgery; baseline data results from the ROSETTA-CABG registry.

Authors:  Rashid Chaudhry; Fahd A Chaudhry; Thao Huynh; Ellis Lader; Saira Rashid; Karen Okrainec; Karen Wou; Mark J Eisenberg
Journal:  Heart Asia       Date:  2010-07-21

Review 2.  The role of smoking cessation in the prevention of coronary artery disease.

Authors:  Andrew L Pipe; Sophia Papadakis; Robert D Reid
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 3.  Cardiovascular disease risk in youth with diabetes mellitus.

Authors:  R Paul Wadwa
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

Review 4.  C-reactive protein as a predictor of disease in smokers and former smokers: a review.

Authors:  S Tonstad; J L Cowan
Journal:  Int J Clin Pract       Date:  2009-08-29       Impact factor: 2.503

5.  Kidney function and tobacco smoke exposure in US adolescents.

Authors:  Esther García-Esquinas; Lauren F Loeffler; Virginia M Weaver; Jeffrey J Fadrowski; Ana Navas-Acien
Journal:  Pediatrics       Date:  2013-04-08       Impact factor: 7.124

6.  Developmental exposure to second-hand smoke increases adult atherogenesis and alters mitochondrial DNA copy number and deletions in apoE(-/-) mice.

Authors:  Jessica L Fetterman; Melissa Pompilius; David G Westbrook; Dale Uyeminami; Jamelle Brown; Kent E Pinkerton; Scott W Ballinger
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

7.  After-hours colorectal surgery: a risk factor for anastomotic leakage.

Authors:  Niels Komen; Jan-Willem Dijk; Zarina Lalmahomed; Karel Klop; Wim Hop; Gert-Jan Kleinrensink; Hans Jeekel; W Ruud Schouten; Johan F Lange
Journal:  Int J Colorectal Dis       Date:  2009-03-21       Impact factor: 2.571

8.  Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers.

Authors:  Sowmya Venkatasubramanian; Radzi Mohd Noh; Shruti Daga; Jeremy P Langrish; Nikhil V Joshi; Nicholas L Mills; Ethan Hoffmann; Eric W Jacobson; George P Vlasuk; Brian R Waterhouse; Ninian N Lang; David E Newby
Journal:  J Am Heart Assoc       Date:  2013-06-14       Impact factor: 5.501

9.  The impact of smoking in adolescence on early adult anxiety symptoms and the relationship between infant vulnerability factors for anxiety and early adult anxiety symptoms: the TOPP Study.

Authors:  Steven Moylan; Kristin Gustavson; Evalill Karevold; Simon Øverland; Felice N Jacka; Julie A Pasco; Michael Berk
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans.

Authors:  Alan G Japp; Raj Chelliah; Laura Tattersall; Ninian N Lang; Xu Meng; Kathleen Weisel; Arie Katz; David Burt; Keith A A Fox; Giora Z Feuerstein; Thomas M Connolly; David E Newby
Journal:  J Am Heart Assoc       Date:  2013-01-28       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.